Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method

5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describ...

Full description

Bibliographic Details
Main Authors: Christelle Machon, Frédéric Catez, Nicole Dalla Venezia, Floriane Vanhalle, Laetitia Guyot, Anne Vincent, Maxime Garcia, Béatrice Roy, Jean-Jacques Diaz, Jérôme Guitton
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Journal of Pharmaceutical Analysis
Subjects:
RNA
DNA
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177919308676
id doaj-4f102c1d02ab4108a7ca82fecdd8f130
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Christelle Machon
Frédéric Catez
Nicole Dalla Venezia
Floriane Vanhalle
Laetitia Guyot
Anne Vincent
Maxime Garcia
Béatrice Roy
Jean-Jacques Diaz
Jérôme Guitton
spellingShingle Christelle Machon
Frédéric Catez
Nicole Dalla Venezia
Floriane Vanhalle
Laetitia Guyot
Anne Vincent
Maxime Garcia
Béatrice Roy
Jean-Jacques Diaz
Jérôme Guitton
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
Journal of Pharmaceutical Analysis
5-Fluorouracil
LC-MS-HRMS
Nucleotide
RNA
DNA
Incorporation rate
author_facet Christelle Machon
Frédéric Catez
Nicole Dalla Venezia
Floriane Vanhalle
Laetitia Guyot
Anne Vincent
Maxime Garcia
Béatrice Roy
Jean-Jacques Diaz
Jérôme Guitton
author_sort Christelle Machon
title Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
title_short Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
title_full Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
title_fullStr Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
title_full_unstemmed Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
title_sort study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an lc-hrms method
publisher Elsevier
series Journal of Pharmaceutical Analysis
issn 2095-1779
publishDate 2021-02-01
description 5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describe the development of a method based on liquid chromatography coupled with high resolution mass spectrometry suitable for the simultaneous determination of the ten anabolic metabolites (nucleoside, nucleotide and sugar nucleotide) of 5-FU. The chromatographic separation was optimized on a porous graphitic carbon column allowing the analysis of the metabolites of 5-FU as well as endogenous nucleotides. The detection was performed on an Orbitrap® tandem mass spectrometer. Linearity of the method was verified in intracellular content and in RNA extracts. The limit of detection was equal to 12 pg injected on column for nucleoside metabolites of 5-FU and 150 pg injected on column for mono- and tri-phosphate nucleotide metabolites. Matrix effect was evaluated in cellular contents, DNA and RNA extracts for nucleoside and nucleotides metabolites. The method was successfully applied to i) measure the proportion of each anabolic metabolite of 5-FU in cellular contents, ii) follow the consequence of inhibition of enzymes on the endogenous nucleotide pools, iii) study the incorporation of metabolites of 5-FU into RNA and DNA, and iv) to determine the incorporation rate of 5-FUrd into 18 S and 28 S sub-units of rRNA.
topic 5-Fluorouracil
LC-MS-HRMS
Nucleotide
RNA
DNA
Incorporation rate
url http://www.sciencedirect.com/science/article/pii/S2095177919308676
work_keys_str_mv AT christellemachon studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT fredericcatez studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT nicoledallavenezia studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT florianevanhalle studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT laetitiaguyot studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT annevincent studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT maximegarcia studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT beatriceroy studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT jeanjacquesdiaz studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
AT jeromeguitton studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod
_version_ 1721547565010255872
spelling doaj-4f102c1d02ab4108a7ca82fecdd8f1302021-04-02T20:16:17ZengElsevierJournal of Pharmaceutical Analysis2095-17792021-02-011117787Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS methodChristelle Machon0Frédéric Catez1Nicole Dalla Venezia2Floriane Vanhalle3Laetitia Guyot4Anne Vincent5Maxime Garcia6Béatrice Roy7Jean-Jacques Diaz8Jérôme Guitton9Laboratoire de Chimie Analytique, Faculté de Pharmacie de Lyon, Université Lyon 1, 8 Avenue Rockefeller, Lyon, 69373, France; Laboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, France; Inserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceLaboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, FranceLaboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInstitut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS, Université de Montpellier, ENSCM, Campus Triolet, Montpellier, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceLaboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, France; Inserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, France; Laboratoire de toxicologie, Faculté de pharmacie de Lyon, 8 avenue Rockefeller, F-69373 Lyon, France; Corresponding author. Laboratoire de Biochimie et de Pharmaco-toxicologie, Centre hospitalier Lyon-Sud – HCL, Pierre Bénite, 69495, France5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describe the development of a method based on liquid chromatography coupled with high resolution mass spectrometry suitable for the simultaneous determination of the ten anabolic metabolites (nucleoside, nucleotide and sugar nucleotide) of 5-FU. The chromatographic separation was optimized on a porous graphitic carbon column allowing the analysis of the metabolites of 5-FU as well as endogenous nucleotides. The detection was performed on an Orbitrap® tandem mass spectrometer. Linearity of the method was verified in intracellular content and in RNA extracts. The limit of detection was equal to 12 pg injected on column for nucleoside metabolites of 5-FU and 150 pg injected on column for mono- and tri-phosphate nucleotide metabolites. Matrix effect was evaluated in cellular contents, DNA and RNA extracts for nucleoside and nucleotides metabolites. The method was successfully applied to i) measure the proportion of each anabolic metabolite of 5-FU in cellular contents, ii) follow the consequence of inhibition of enzymes on the endogenous nucleotide pools, iii) study the incorporation of metabolites of 5-FU into RNA and DNA, and iv) to determine the incorporation rate of 5-FUrd into 18 S and 28 S sub-units of rRNA.http://www.sciencedirect.com/science/article/pii/S20951779193086765-FluorouracilLC-MS-HRMSNucleotideRNADNAIncorporation rate